Balance Sheet
Accounts PayablesAssetsCommon EquityLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Exousia Bio (LMMY) Total Current Liabilities (2023 - 2025)

Lamy (LMMY) has disclosed Total Current Liabilities for 3 consecutive years, with $261023.0 as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities changed N/A to $261023.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $261023.0 through Nov 2025, changed N/A year-over-year, with the annual reading at $14169.0 for FY2024, 292.49% up from the prior year.
  • Total Current Liabilities hit $261023.0 in Q4 2025 for Lamy, up from $35314.0 in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $261023.0 in Q4 2025 to a low of $3000.0 in Q1 2023.
  • Historically, Total Current Liabilities has averaged $39384.8 across 3 years, with a median of $9819.0 in 2024.
  • Biggest five-year swings in Total Current Liabilities: soared 314.21% in 2024 and later skyrocketed 105.68% in 2025.
  • Year by year, Total Current Liabilities stood at $6214.0 in 2023, then skyrocketed by 176.3% to $17169.0 in 2024, then surged by 1420.32% to $261023.0 in 2025.
  • Business Quant data shows Total Current Liabilities for LMMY at $261023.0 in Q4 2025, $35314.0 in Q3 2025, and $17169.0 in Q3 2024.